Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.
When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.
Laboratoire de Bactériologie, Hôpital Debrousse, Hospices Civils de Lyon, Lyon, France. anne-marie.freydiere@chu-lyon.fr
A M
AM
Freydiere
J D
JD
Perry
O
O
Faure
B
B
Willinger
A M
AM
Tortorano
A
A
Nicholson
J
J
Peman
P E
PE
Verweij
D041221:Candida glabrata / Q000145:classification* / Q000302:isolation & purification*; D002177:Candidiasis / Q000382:microbiology*; D003470:Culture Media; D006801:Humans; D007753:Laboratories; D016533:Mycological Typing Techniques; D011933:Reagent Kits, Diagnostic; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013997:Time Factors
D003470:Culture Media; D011933:Reagent Kits, Diagnostic